https://www.marketscreener.com/quote/stock/IMMUNEERING-CORPORATION-125277856/news/Immuneering-Announces-First-Patient-Dosed-in-its-Phase-1-2a-Trial-of-IMM-6-415-to-Treat-Advanced-Sol-46299156/?utm_source=telegram&utm_medium=social&utm_campaign=share